Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RedNic: Reduced Nicotine Cigarettes in Smokers With/Without Alcohol Use Disorder
NCT02990455Phase 1Completed
- Sponsor
- Battelle
- Start
- Nov 2017
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cigarette reduced nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Battelle. Primary endpoint: Alcohol drinks per day at 7 days. Started Nov 2017; status: completed.
02
Drugs
cigarette reduced nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02990455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02990455.